ATE322502T1 - Membran-assoziierte immunogene proteine des mycobakterien - Google Patents
Membran-assoziierte immunogene proteine des mycobakterienInfo
- Publication number
- ATE322502T1 ATE322502T1 AT93916768T AT93916768T ATE322502T1 AT E322502 T1 ATE322502 T1 AT E322502T1 AT 93916768 T AT93916768 T AT 93916768T AT 93916768 T AT93916768 T AT 93916768T AT E322502 T1 ATE322502 T1 AT E322502T1
- Authority
- AT
- Austria
- Prior art keywords
- mycobacteria
- bovis bcg
- antigen
- useful
- tuberculosis
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 102000036639 antigens Human genes 0.000 abstract 6
- 108091007433 antigens Proteins 0.000 abstract 6
- 239000000427 antigen Substances 0.000 abstract 5
- 241001467552 Mycobacterium bovis BCG Species 0.000 abstract 4
- 201000008827 tuberculosis Diseases 0.000 abstract 3
- 239000012528 membrane Substances 0.000 abstract 2
- 108091006112 ATPases Proteins 0.000 abstract 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 abstract 1
- 238000012408 PCR amplification Methods 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/906,395 US5330754A (en) | 1992-06-29 | 1992-06-29 | Membrane-associated immunogens of mycobacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322502T1 true ATE322502T1 (de) | 2006-04-15 |
Family
ID=25422375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93916768T ATE322502T1 (de) | 1992-06-29 | 1993-06-28 | Membran-assoziierte immunogene proteine des mycobakterien |
Country Status (8)
Country | Link |
---|---|
US (5) | US5330754A (de) |
EP (1) | EP0649435B1 (de) |
JP (2) | JP4053085B2 (de) |
AT (1) | ATE322502T1 (de) |
AU (1) | AU689075B2 (de) |
CA (1) | CA2138970A1 (de) |
DE (1) | DE69334002T2 (de) |
WO (1) | WO1994000493A1 (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2682967B1 (fr) * | 1991-10-25 | 1994-01-14 | Pasteur Institut | Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques. |
US5330754A (en) * | 1992-06-29 | 1994-07-19 | Archana Kapoor | Membrane-associated immunogens of mycobacteria |
CA2156191A1 (en) * | 1993-02-22 | 1994-09-01 | Stephen B. Calderwood | Heterologous antigens in live cell vaccine strains |
US6991797B2 (en) * | 1993-07-02 | 2006-01-31 | Statens Serum Institut | M. tuberculosis antigens |
US5955077A (en) * | 1993-07-02 | 1999-09-21 | Statens Seruminstitut | Tuberculosis vaccine |
WO1996037219A1 (en) * | 1995-05-23 | 1996-11-28 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
US6290969B1 (en) | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
ATE324445T1 (de) * | 1995-09-01 | 2006-05-15 | Corixa Corp | Verbindungen und verfahren zur diagnose von tuberkulose |
US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
EP1712629A3 (de) * | 1995-09-01 | 2009-09-09 | Corixa Corporation | Verbindungen und Verfahren zur Diagnose von Tuberkulose |
US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
IL123506A (en) * | 1995-09-01 | 2004-12-15 | Corixa Corp | Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis |
US6338852B1 (en) | 1995-09-01 | 2002-01-15 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
GB9604045D0 (en) * | 1996-02-26 | 1996-04-24 | Smithkline Beecham Plc | Novel compounds |
USRE40351E1 (en) | 1996-07-24 | 2008-06-03 | Lincoln Global, Inc. | Mechanism for braking the unwinding of a bundle of metallic wire housed in a drum |
EP1007688B1 (de) | 1996-07-26 | 2008-05-21 | Institut Pasteur | Desaturase-antigen aus mycobakterium tubercolosis |
AU723380B2 (en) | 1996-09-06 | 2000-08-24 | Peter Ruhdal Jensen | A method of improving the production of biomass or a desired product from a cell |
CZ126699A3 (cs) * | 1996-10-11 | 1999-09-15 | Corixa Corporation | Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity |
AU7410798A (en) * | 1996-11-29 | 1998-06-22 | General Hospital Corporation, The | Heterologous antigens in live cell V |
US6245331B1 (en) * | 1997-01-02 | 2001-06-12 | New York Univ. Medical Center | Early detection of mycobacterial disease |
US6506384B1 (en) | 1997-12-31 | 2003-01-14 | New York University | Early detection of mycobacterial disease |
US7807182B2 (en) * | 1996-12-31 | 2010-10-05 | Colorado State University Research Foundation | Early detection of mycobacterial disease using peptides |
US6544522B1 (en) * | 1998-12-30 | 2003-04-08 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6350456B1 (en) | 1997-03-13 | 2002-02-26 | Corixa Corporation | Compositions and methods for the prevention and treatment of M. tuberculosis infection |
US6627198B2 (en) | 1997-03-13 | 2003-09-30 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis antigens and their uses |
US6982085B2 (en) * | 1997-04-02 | 2006-01-03 | Statens Serum Institut | TB diagnostic based on antigens from M. tuberculosis |
US7037510B2 (en) | 1997-04-18 | 2006-05-02 | Statens Serum Institut | Hybrids of M. tuberculosis antigens |
US6613881B1 (en) | 1997-05-20 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
US6555653B2 (en) | 1997-05-20 | 2003-04-29 | Corixa Corporation | Compounds for diagnosis of tuberculosis and methods for their use |
US6545130B2 (en) * | 1997-06-04 | 2003-04-08 | Albert Einstein College Of Medicine Of Yeshiva University | Monoclonal antibodies to mycobacterium tuberculosis and a modified ELISA assay |
US20040013685A1 (en) * | 1997-11-10 | 2004-01-22 | Peter Andersen | Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
AU753995B2 (en) * | 1998-04-07 | 2002-10-31 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6165736A (en) * | 1998-07-28 | 2000-12-26 | The Nemours Foundation | Method of detecting bacterial infection |
US6465633B1 (en) | 1998-12-24 | 2002-10-15 | Corixa Corporation | Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis |
US7022320B1 (en) * | 1999-02-09 | 2006-04-04 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis immunization |
US8143386B2 (en) * | 1999-04-07 | 2012-03-27 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
EP1240519B1 (de) * | 1999-06-14 | 2007-01-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services | Kompositionen und verfahren zum nachweis von treponema pallidum |
WO2001024820A1 (en) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
AU2001241738A1 (en) * | 2000-02-25 | 2001-09-03 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
US6929910B2 (en) * | 2000-04-19 | 2005-08-16 | The Regents Of The University Of California | Diagnostic and therapeutic methods using the H37 tumor suppressor gene |
ATE442866T1 (de) * | 2000-06-20 | 2009-10-15 | Corixa Corp | Fusionsproteine aus mycobakterium tuberculosis |
GB0022017D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Dundee | Cell assays |
US6916611B2 (en) * | 2001-02-26 | 2005-07-12 | The Regents Of The University Of California | Expression vector system and a method for optimization and confirmation of DNA delivery and quantification of targeting frequency |
WO2003012395A2 (en) * | 2001-08-02 | 2003-02-13 | New York University | Early detection of mycobacterial disease using peptides |
US20050267025A1 (en) * | 2002-02-01 | 2005-12-01 | Ho John L | Compositions and methods for treatment of infectious and inflammatory diseases |
AU2003210818A1 (en) * | 2002-02-01 | 2003-09-02 | Cornell Research Foundation, Inc. | Compositions and methods for treatment of infectious and inflammatory diseases |
US7026465B2 (en) | 2002-02-15 | 2006-04-11 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis |
AU2003215034A1 (en) | 2002-03-12 | 2003-11-10 | Hemofarm Koncern A.D. Pharmaceutical And Chemical Industry | Diagnostic method for spectroscopic detection of tuberculosis |
US6913145B2 (en) | 2003-04-15 | 2005-07-05 | Lincoln Global, Inc. | Welding wire container with ribbed walls and a mating retainer ring |
CN1787741B (zh) * | 2003-05-15 | 2011-08-17 | 唐纳士公司 | 用于预防和治疗败血症的方法与组合物 |
US7222734B2 (en) | 2004-07-15 | 2007-05-29 | Lincoln Global, Inc. | Welding wire package with lifting strap |
US7377388B2 (en) | 2004-11-15 | 2008-05-27 | Lincoln Global, Inc. | Welding wire package |
US8882018B2 (en) | 2011-12-19 | 2014-11-11 | Sidergas Spa | Retainer for welding wire container and welding wire container with retainer |
US10294065B2 (en) | 2013-06-06 | 2019-05-21 | Sidergas Spa | Retainer for a welding wire container and welding wire container |
US10343231B2 (en) | 2014-05-28 | 2019-07-09 | Awds Technologies Srl | Wire feeding system |
US10010962B1 (en) | 2014-09-09 | 2018-07-03 | Awds Technologies Srl | Module and system for controlling and recording welding data, and welding wire feeder |
US10350696B2 (en) | 2015-04-06 | 2019-07-16 | Awds Technologies Srl | Wire feed system and method of controlling feed of welding wire |
US9950857B1 (en) | 2016-10-17 | 2018-04-24 | Sidergas Spa | Welding wire container |
WO2019144139A1 (en) * | 2018-01-22 | 2019-07-25 | Oregon State University | Immunogenic compositions comprising mycobacterium bovis surface proteins and uses thereof |
US11174121B2 (en) | 2020-01-20 | 2021-11-16 | Awds Technologies Srl | Device for imparting a torsional force onto a wire |
US11278981B2 (en) | 2020-01-20 | 2022-03-22 | Awds Technologies Srl | Device for imparting a torsional force onto a wire |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0323480A1 (de) * | 1986-09-08 | 1989-07-12 | Applied Biotechnology, Inc. | Genetisch veränderte impfstoffe gegen mykobakterien |
US5504005A (en) * | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
FR2677365B1 (fr) * | 1991-06-07 | 1995-08-04 | Pasteur Institut | Proteines de mycobacterium et applications. |
EP0625052A4 (de) * | 1991-10-21 | 1995-07-19 | Medimmune Inc | Sekretionssignal von lipoproteinen kodierende dna enthaltener bakterieller expressionsvektor. |
US5330754A (en) * | 1992-06-29 | 1994-07-19 | Archana Kapoor | Membrane-associated immunogens of mycobacteria |
-
1992
- 1992-06-29 US US07/906,395 patent/US5330754A/en not_active Expired - Lifetime
-
1993
- 1993-06-28 AT AT93916768T patent/ATE322502T1/de not_active IP Right Cessation
- 1993-06-28 JP JP50259494A patent/JP4053085B2/ja not_active Expired - Fee Related
- 1993-06-28 CA CA002138970A patent/CA2138970A1/en not_active Abandoned
- 1993-06-28 WO PCT/US1993/006080 patent/WO1994000493A1/en active IP Right Grant
- 1993-06-28 DE DE69334002T patent/DE69334002T2/de not_active Expired - Fee Related
- 1993-06-28 EP EP93916768A patent/EP0649435B1/de not_active Expired - Lifetime
- 1993-06-28 AU AU46511/93A patent/AU689075B2/en not_active Ceased
-
1994
- 1994-02-07 US US08/192,632 patent/US5559011A/en not_active Expired - Fee Related
-
1996
- 1996-09-23 US US08/710,676 patent/US5770719A/en not_active Expired - Fee Related
-
1998
- 1998-06-18 US US09/099,902 patent/US6045798A/en not_active Expired - Fee Related
-
1999
- 1999-11-02 US US09/432,820 patent/US7355016B2/en not_active Expired - Fee Related
-
2007
- 2007-10-03 JP JP2007260131A patent/JP2008086322A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69334002T2 (de) | 2007-04-19 |
WO1994000493A1 (en) | 1994-01-06 |
US5330754A (en) | 1994-07-19 |
US20030099673A1 (en) | 2003-05-29 |
JP4053085B2 (ja) | 2008-02-27 |
US5770719A (en) | 1998-06-23 |
US6045798A (en) | 2000-04-04 |
US7355016B2 (en) | 2008-04-08 |
DE69334002D1 (de) | 2006-05-18 |
EP0649435A4 (de) | 1996-12-27 |
US5559011A (en) | 1996-09-24 |
JPH07508649A (ja) | 1995-09-28 |
AU689075B2 (en) | 1998-03-26 |
AU4651193A (en) | 1994-01-24 |
EP0649435A1 (de) | 1995-04-26 |
CA2138970A1 (en) | 1994-01-06 |
JP2008086322A (ja) | 2008-04-17 |
EP0649435B1 (de) | 2006-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322502T1 (de) | Membran-assoziierte immunogene proteine des mycobakterien | |
Norton et al. | Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis | |
Pozzi et al. | Delivery and expression of a heterologous antigen on the surface of streptococci | |
JP4283872B2 (ja) | 微生物蛋白質と、この蛋白質を産生する微生物と、該蛋白質のワクチンおよび結核検出での利用 | |
Ruffolo et al. | Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen | |
US7038012B1 (en) | Enrichment process for H. pylori neutrophil activating protein (NAP) utilizing metal chelate chromatography | |
Dallo et al. | Identification of P1 gene domain containing epitope (s) mediating Mycoplasma pneumoniae cytoadherence. | |
Anderson et al. | Cloning and expression in Escherichia coli of the gene encoding the structural subunit of Bacteroides nodosus fimbriae | |
JPS61289888A (ja) | ワクシニアdna | |
JP2001503245A (ja) | ボレリア属dnaを投与するための組成物および方法 | |
CZ280743B6 (cs) | Imunogen proti lymské boreliose savců | |
JP2004507217A (ja) | リステリア菌ゲノム、ポリペプチドおよびその使用 | |
JP2007332149A (ja) | マイコバクテリア感染症に対するワクチン | |
JP2004515227A (ja) | リステリア・インノキュア、ゲノムおよびその用途 | |
Hogervorst et al. | Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus | |
CN108330142B (zh) | 一种具有免疫保护作用的美人鱼发光杆菌溶血素Hlych蛋白 | |
Charles et al. | Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system | |
Haeseleer et al. | Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria | |
Lo et al. | Characterization of two lipoproteins in Pasteurella multocida | |
RU2313535C2 (ru) | Пептид neisseria meningitidis для терапевтического и диагностического применения | |
Street et al. | Differences in the effectiveness of delivery of B-and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region | |
RU2102081C1 (ru) | Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi | |
Lo et al. | The isolation of recombinant plasmids expressing secreted antigens of Pasteurella haemolytica A1 and the characterization of an immunogenic 60 kDa antigen | |
AU751646B2 (en) | Hepatitis B virus polypeptides | |
Mader et al. | The mature MgPa-adhesin of Mycoplasma genitalium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |